Keyphrases
Clinical Outcomes
100%
Prospective Observational Study
100%
Bronchiectasis
100%
Sputum Microbiome
100%
Microbiome
55%
Pseudomonas
44%
Microbial Diversity
33%
Sputum Samples
33%
Enterobacteriaceae
22%
All-cause Mortality
22%
Clinically Stable
22%
Frequent Exacerbator
22%
Bronchiectasis Severity Index
22%
Random Forest Analysis
22%
Scotland
11%
Treatment Strategy
11%
One Sample
11%
Mortality Risk
11%
Longitudinal Analysis
11%
Pathophysiology
11%
Clinical Severity
11%
Confirmed Diagnosis
11%
High Risk
11%
Hazard Ratio
11%
Disease Severity
11%
Poor Outcome
11%
Clinical Symptoms
11%
Forced Expiratory Volume in 1 Second (FEV1)
11%
Mortality Hazard
11%
Firmicutes
11%
Severe Symptoms
11%
Survival Analysis
11%
High-resolution CT
11%
Bacterial Genera
11%
Bacterial 16S rRNA Gene
11%
Sequence Data
11%
Proteobacteria
11%
Lung Inflammation
11%
Incident Rate Ratio
11%
Disease Stability
11%
Stenotrophomonas
11%
Exacerbation Risk
11%
Microbial Profile
11%
Shannon Diversity Index
11%
Precision Treatment
11%
Dominant Genera
11%
Stable Baselines
11%
Traditional Culture Method
11%
Exacerbation Severity
11%
V3-V4 Region
11%
Illumina MiSeq Platform
11%
Immunology and Microbiology
Microbiome
100%
Sputum
100%
Pseudomonas
36%
Enterobacteriaceae
18%
All Cause Mortality
18%
Random Forest
18%
RNA Gene
9%
Firmicutes
9%
Pulmonary Inflammation
9%
Proteobacteria
9%
Stenotrophomonas
9%
Illumina MiSeq
9%